Home › Funds › Velan Capital Investment Management LP › PROF
Velan Capital Investment Management LP position in PROF
PROFOUND MED CORP · Health Care
Velan Capital Investment Management LP reported holding 170,278 shares of PROF (PROFOUND MED CORP) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.72% of its reported portfolio and ranking #21 among its reported holdings. Velan Capital Investment Management LP has disclosed PROF holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's PROF position evolved
Velan Capital Investment Management LP first disclosed a stake in PROF in Q4 2025 at 285,710 shares (US$2.2M). Across 3 filings, Velan Capital Investment Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 170,278 shares valued at US$1.1M — a reduction of -115,432 shares quarter over quarter.. Notable position changes include a 40% trim in Q2 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 285.71K | $2.25M | New |
| Q1 2026 | 285.71K | $1.85M | Hold |
| Q2 2026 | 170.28K | $1.13M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PROF and 13F data
PROF (PROFOUND MED CORP) is a Health Care company. 31 other funds we track also report a position in PROF — the largest reported positions include GAGNON SECURITIES LLC (US$13.0M), Timelo Investment Management Inc. (US$7.4M), Gagnon Advisors, LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PROF
- GAGNON SECURITIES LLC 1.96M sh · $13.03M · Q2 2026
- Timelo Investment Management Inc. 1.11M sh · $7.41M · Q2 2026
- Gagnon Advisors, LLC 962.19K sh · $6.40M · Q2 2026
- Rosalind Advisors, Inc. 828.12K sh · $5.51M · Q2 2026
- Z3 Capital Partners, LLC 820.94K sh · $5.46M · Q2 2026
- Lagoda Investment Management, L.P. 501.32K sh · $3.33M · Q2 2026
- Ring Mountain Capital, LLC 521.13K sh · $3.02M · Q3 2026
- PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 276.00K sh · $1.79M · Q1 2026
- DAFNA Capital Management LLC 260.36K sh · $1.73M · Q2 2026
- Bleichroeder LP 254.75K sh · $1.69M · Q2 2026
- THOMPSON DAVIS & CO., INC. 216.53K sh · $1.44M · Q2 2026
- Dauntless Investment Group, LLC 208.37K sh · $1.39M · Q2 2026
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held PROF?
Velan Capital Investment Management LP has disclosed PROF holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Velan Capital Investment Management LP's current position in PROF?
As of Q2 2026, Velan Capital Investment Management LP holds 170.28K shares of PROF (PROFOUND MED CORP), valued at $1.13M, representing 0.72% of its reported portfolio and ranking #21.
Has Velan Capital Investment Management LP been buying or selling PROF?
In the latest 13F filing (Q2 2026), Velan Capital Investment Management LP reduced its position in PROF.
Which other funds hold PROF?
Other major institutional holders of PROF include GAGNON SECURITIES LLC, Timelo Investment Management Inc., Gagnon Advisors, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.